Brivanib alaninate
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Brivanib alaninate, covering 2015-07-07 to 2017-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]